April 1, 2024

68Ga-DOTATATE and 68Ga-FAPI Imaging in Neuroendocrine Neoplasms of Different Grades

YZYue ZhouWestern University LOLei OuChongqing University SYSongke YuGuangxi Normal University

Key Points

Key points are not available for this paper at this time.

Abstract

Abstract We report findings from 68 Ga-DOTATATE and 68 Ga-FAPI PET/CT in a 43-year-old woman with neuroendocrine neoplasms. DOTATATE and FAPI uptake differed in different lesions. These results suggest a potential value for dual-tracer imaging in the evaluation of neuroendocrine neoplasms that have different grades.

AIに質問

Bookmark

View Full Paper

Cite This Study

Zhou et al. (Mon,) studied this question.

synapsesocial.com/papers/68e7103bb6db643587689f7c https://doi.org/https://doi.org/10.1097/rlu.0000000000005203

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

168Ga-DOTATATE PET/MRI for Neuroendocrine Tumors2020 · 6 citations
2177Lu-Dotatate for midgut neuroendocrine tumours2017 · 5 citations
3177Lu-Dotatate plus long-acting octreotide versus high‑dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial2021 · 551 citations
4The superiority of [68Ga]Ga-FAPI-04 over [18F]-FDG in a case of neuroendocrine tumour with hepatic metastasis2021 · 27 citations
5Increased 68Ga-FAPI Activity in Primary Small Cell Neuroendocrine Carcinoma of the Gallbladder2023 · 2 citations

AIに質問

Bookmark

View Full Paper